Physician profile
Payam Daneshrad
NPI 1902959307
$23,914.78
in general payments reported to CMS, 2019-2025
22 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,711 · 2020: $13K · 2021: $4,431 · 2022: $783 · 2023: $1,328 · 2024: $1,193 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,689.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18,573.98 | 2019-2024 | Xpress Ent Dilation System, Scopis Ent, Xpress Loprofile |
| Regeneron Healthcare Solutions, INC. | $1,408.75 | 2019-2025 | Dupixent |
| Abbvie INC. | $854.68 | 2023-2024 | Botox |
| Intersect Ent, INC. | $685.70 | 2019-2021 | |
| Glaxosmithkline, LLC. | $461.56 | 2022-2025 | Nucala |
| Revance Therapeutics, INC. | $432.32 | 2025 | Daxxify |
| Genzyme Corporation | $327.60 | 2019-2025 | |
| Integra Lifesciences Corporation | $295.61 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Merz North America, INC. | $160.23 | 2023 | Xeomin |
| Preceptis Medical, INC. | $138.92 | 2024 | Hummingbird Tympanostomy Tube System |
| Optinose US, INC. | $118.02 | 2022-2024 | |
| Acclarent, INC | $117.23 | 2019-2021 | |
| Aerin Medical INC. | $107.74 | 2020-2024 | |
| Medtronic, INC. | $56.52 | 2023-2024 | Nuvent, Propel |
| Medical Device Business Services, INC. | $46.82 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $20.62 | 2023 | Odactra, Ragwitek, Grastek |
| Kaleo, INC. | $20.18 | 2019 | |
| Organogenesis INC. | $19.90 | 2019 | |
| Itamar Medical INC | $19.86 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.89 | 2023 | Seglentis |
| Allergan, INC. | $15.55 | 2022 | |
| Davol INC. | $15.10 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payam Daneshrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.